Search Results 771-780 of 15965 for melatonin receptor agonists

1. Pilot Study of Rituximab to Treat Fibrillary Glomerulonephritis - Mayo Clinic

   Will use of Rituximab reduce proteinuria over a 12 month period and will there be preservation of kidney function with the use of this study drug? Participation ...

2. Headache medicine ergot-derivative-containing (oral route, parenteral route, rectal route) - Mayo Clinic

   Dihydroergotamine and ergotamine belong to the group of medicines known as ergot alkaloids. They are used to treat severe, throbbing headaches, such as migraine ...

3. A Study to Evaluate Intravenous Erenumab in Patients with Status Migrainosus - Mayo Clinic

   Past (within 4 months) or present exposure to a CGRP monoclonal antibody or CGRP small molecule receptor antagonist for migraine treatment. Present exposure ...

4. Prospective Tissue Collection of Hepatic Epithelia: - Mayo Clinic

   The purpose of this research study is to improve our understanding of normal liver and gallbladder function and liver and gallbladder diseases including PBC, ...

5. Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer - Mayo Clinic

   Monoclonal antibodies, such as pembrolizumab, may block tumor growth in different ways by targeting certain cells. Binimetinib may stop the growth of tumor ...

6. A Study to Evaluate the Effectiveness, Safety, and Tolerability of NLY01 in Early-stage Parkinson's Disease - Mayo Clinic

   Prior exposure to exenatide or other GLP-1R agonists. Prior exposure to NLY01. Participating Mayo Clinic locations. Study statuses change often. Please ...

7. Faculty - Department of Molecular Pharmacology and Experimental Therapeutics Research - Mayo Clinic Research

   Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...

8. A Study Evaluating the Safety and Effectiveness of UCART Targeting CS1 in Patients with Relapsed/Refractory Multiple Myeloma (MELANI-01) - Mayo Clinic

   No previous treatment with investigational gene targeting CS1 or chimeric antigen receptor therapy targeting CS1. Adequate organ function, including bone ...

9. Core needle biopsy of urothelial lesion - Mayo Clinic

   Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine. Donate · Find a doctor · Explore careers.

10. Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) - Mayo Clinic

    Treatment with luteinizing hormone-releasing hormone agonists or ... receptor activator of nuclear factor kappa-? ligand inhibitor) must be on ...